Kovitz Investment Group Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-8,979
| Closed | -$1.65M | – | 437 |
|
|
2021
Q2 | $1.65M | Buy |
8,979
+329
| +4% | +$60.5K | 0.03% | 252 |
|
|
2021
Q1 | $1.32M | Buy |
8,650
+2,380
| +38% | +$364K | 0.03% | 251 |
|
|
2020
Q4 | $980K | Sell |
6,270
-470
| -7% | -$73.5K | 0.02% | 269 |
|
|
2020
Q3 | $771K | Buy |
6,740
+95
| +1% | +$10.9K | 0.02% | 278 |
|
|
2020
Q2 | $746K | Sell |
6,645
-3,315
| -33% | -$372K | 0.02% | 278 |
|
|
2020
Q1 | $894K | Buy |
9,960
+2,475
| +33% | +$222K | 0.03% | 252 |
|
|
2019
Q4 | $810K | Sell |
7,485
-3,048
| -29% | -$330K | 0.02% | 283 |
|
|
2019
Q3 | $1.03M | Buy |
10,533
+4,465
| +74% | +$437K | 0.03% | 260 |
|
|
2019
Q2 | $794K | Buy |
6,068
+630
| +12% | +$82.4K | 0.03% | 284 |
|
|
2019
Q1 | $735K | Buy |
+5,438
| New | +$735K | 0.02% | 298 |
|